GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » Capex-to-Operating-Income

Nanalysis Scientific (TSXV:NSCI) Capex-to-Operating-Income : 0.00 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Nanalysis Scientific's Capital Expenditure for the three months ended in Mar. 2024 was C$-0.58 Mil. Its Operating Income for the three months ended in Mar. 2024 was C$-1.71 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Nanalysis Scientific Capex-to-Operating-Income Historical Data

The historical data trend for Nanalysis Scientific's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific Capex-to-Operating-Income Chart

Nanalysis Scientific Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial 54.12 - - - -

Nanalysis Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nanalysis Scientific's Capex-to-Operating-Income

For the Scientific & Technical Instruments subindustry, Nanalysis Scientific's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanalysis Scientific's Capex-to-Operating-Income Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Nanalysis Scientific's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Nanalysis Scientific's Capex-to-Operating-Income falls into.



Nanalysis Scientific Capex-to-Operating-Income Calculation

Nanalysis Scientific's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-4.592) / -13.514
=N/A

Nanalysis Scientific's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.578) / -1.706
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanalysis Scientific  (TSXV:NSCI) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Nanalysis Scientific Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanalysis Scientific (TSXV:NSCI) Business Description

Traded in Other Exchanges
Address
Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3
Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.
Executives
Michal Okoniewski Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines